Volume 138, Issue 3, Pages 922-931.e1 (March 2010) Adverse Outcomes in Alaska Natives Who Recovered From or Have Chronic Hepatitis C Infection Brian J. McMahon, Dana Bruden, Michael G. Bruce, Stephen Livingston, Carol Christensen, Chriss Homan, Thomas W. Hennessy, James Williams, Daniel Sullivan, Hugo R. Rosen, David Gretch Gastroenterology Volume 138, Issue 3, Pages 922-931.e1 (March 2010) DOI: 10.1053/j.gastro.2009.10.056 Copyright © 2010 AGA Institute Terms and Conditions
Figure 1 Flow diagram for Alaska Native persons tested for HCV from start of program to December 31, 2005. RIBA, recombinant immunoblot assay; PCR, polymerase chain reaction. Gastroenterology 2010 138, 922-931.e1DOI: (10.1053/j.gastro.2009.10.056) Copyright © 2010 AGA Institute Terms and Conditions
Figure 2 Survival probability for free from ESLD or LRD survival among a cohort of 695 AN persons chronically infected with HCV followed from 1994 to 2005. Predicted probabilities are calculated for a person infected with HCV at 25 years of age. ETOH, ethyl alcohol. Gastroenterology 2010 138, 922-931.e1DOI: (10.1053/j.gastro.2009.10.056) Copyright © 2010 AGA Institute Terms and Conditions